Should Peptide Purification Launch Require Action From DuPont (DD) Investors?

DuPont de Nemours recently introduced AmberChrom SIL silica gel, a reverse phase silica media in C8 and C18 chemistries for demanding peptide purification, including GLP-1 receptor agonists. This expands its bioprocessing purification portfolio. The launch pushes DuPont de Nemours deeper into biopharma process consumables, an area where recurring demand and high purity requirements can help anchor long-term customer relationships. The focus now turns to how DuPont de Nemours' broader...